Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 7 | 2022 | 1533 | 0.770 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2018 | 114 | 0.540 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2018 | 107 | 0.490 |
Why?
|
| Stromal Cells | 4 | 2022 | 113 | 0.460 |
Why?
|
| Fibroblasts | 3 | 2023 | 902 | 0.370 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2009 | 22 | 0.360 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2022 | 231 | 0.220 |
Why?
|
| Oncogenes | 1 | 2022 | 71 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 756 | 0.210 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 2 | 2013 | 49 | 0.210 |
Why?
|
| Pancreas | 1 | 2023 | 225 | 0.200 |
Why?
|
| Epithelial Cells | 4 | 2019 | 431 | 0.200 |
Why?
|
| Mice | 10 | 2023 | 8472 | 0.200 |
Why?
|
| Mesoderm | 3 | 2023 | 231 | 0.200 |
Why?
|
| Gene Deletion | 4 | 2013 | 235 | 0.200 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 332 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2023 | 235 | 0.170 |
Why?
|
| Radiation Tolerance | 1 | 2018 | 30 | 0.160 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 1032 | 0.160 |
Why?
|
| Estrogens | 1 | 2019 | 173 | 0.160 |
Why?
|
| Carcinogenesis | 4 | 2023 | 124 | 0.160 |
Why?
|
| Cell Compartmentation | 2 | 2014 | 41 | 0.150 |
Why?
|
| Breast Feeding | 1 | 2019 | 159 | 0.150 |
Why?
|
| Animals | 11 | 2023 | 20877 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2020 | 447 | 0.130 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2014 | 21 | 0.120 |
Why?
|
| Adenomatous Polyps | 1 | 2014 | 18 | 0.120 |
Why?
|
| Intestines | 1 | 2014 | 114 | 0.120 |
Why?
|
| Inflammation | 1 | 2019 | 1030 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2019 | 2688 | 0.110 |
Why?
|
| Stem Cells | 1 | 2014 | 248 | 0.110 |
Why?
|
| Palatine Tonsil | 1 | 2012 | 8 | 0.110 |
Why?
|
| Lymphopoiesis | 1 | 2012 | 16 | 0.110 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 94 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 126 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2018 | 1173 | 0.090 |
Why?
|
| Retinoblastoma Protein | 2 | 2014 | 75 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2009 | 156 | 0.080 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2008 | 2 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2008 | 3 | 0.080 |
Why?
|
| Pregnancy | 2 | 2019 | 2331 | 0.080 |
Why?
|
| Loss of Heterozygosity | 1 | 2008 | 25 | 0.080 |
Why?
|
| Genes, myc | 1 | 2008 | 26 | 0.080 |
Why?
|
| Cell Lineage | 2 | 2012 | 146 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 369 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 493 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 1849 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 498 | 0.060 |
Why?
|
| Humans | 8 | 2020 | 68525 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 176 | 0.050 |
Why?
|
| Connective Tissue | 1 | 2022 | 61 | 0.050 |
Why?
|
| Placenta | 1 | 2003 | 101 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 78 | 0.050 |
Why?
|
| Homeostasis | 1 | 2023 | 291 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 2790 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 1174 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 20 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2019 | 89 | 0.040 |
Why?
|
| Female | 5 | 2019 | 38015 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 2550 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 142 | 0.040 |
Why?
|
| Steroids | 1 | 2019 | 84 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 179 | 0.040 |
Why?
|
| Lactation | 1 | 2019 | 110 | 0.040 |
Why?
|
| Gamma Rays | 1 | 2018 | 64 | 0.040 |
Why?
|
| Mammary Glands, Human | 1 | 2018 | 33 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2019 | 489 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2018 | 41 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2018 | 71 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 539 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2020 | 384 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2018 | 239 | 0.040 |
Why?
|
| Neoplasms | 1 | 2008 | 1660 | 0.040 |
Why?
|
| Collagen | 1 | 2019 | 636 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 331 | 0.030 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2014 | 15 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 90 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 219 | 0.030 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2013 | 44 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 2004 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 7 | 0.030 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2012 | 27 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2012 | 29 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2012 | 110 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2012 | 97 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2012 | 167 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2008 | 1692 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 230 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 157 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 1070 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 268 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 981 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1037 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 370 | 0.020 |
Why?
|
| Brain | 1 | 2020 | 2175 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5719 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 1213 | 0.020 |
Why?
|
| Vimentin | 1 | 2008 | 47 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2008 | 93 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1640 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 492 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 320 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 284 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 1034 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2003 | 17 | 0.010 |
Why?
|
| Trophoblasts | 1 | 2003 | 29 | 0.010 |
Why?
|
| Fetus | 1 | 2003 | 157 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2003 | 222 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 541 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 7028 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1663 | 0.010 |
Why?
|
| Male | 1 | 2003 | 37281 | 0.000 |
Why?
|